Portfolio company
Variational AI
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops a generative artificial intelligence platform for small molecule drug discovery for biopharmaceutical and biotechnology organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Variartional
This company develops generative artificial intelligence to accelerate the discovery and optimization of novel small molecules for biopharmaceutical researchers and drug developers.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Valence Discovery
This company provides a machine learning platform for molecular design and lead optimisation to pharmaceutical and biotechnology firms.
Avicenna Biosciences
The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.
Genesis Molecular AI
The company develops an artificial intelligence platform for molecular drug discovery to assist pharmaceutical firms in designing and optimising small molecule medicines.
Terray
This company develops a generative artificial intelligence and high-throughput experimentation platform for pharmaceutical and biotechnology organisations to accelerate small molecule drug discovery.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Chai Discovery
This company develops artificial intelligence models to predict and design molecular structures and protein binders for pharmaceutical and life sciences researchers.
